24.2% Growth Rate for Autoinjectors Market to 2023 - Global Forecast, Trends, Opportunity and Industry Analysis
Report analyzes autoinjectors market and aims at estimating size and future growth potential of this market based on various segments like therapy, type, end user, and region. Detailed insights on upcoming technologies, research and development activities
(EMAILWIRE.COM, December 11, 2018 ) Autoinjectors market are easy-to-handle and cost-effective medical devices that can be used by patients, caregivers, and even untrained personnel to deliver a dose of a particular drug. Autoinjectors are used by patients to manage autoimmune diseases and chronic diseases. They are used for a wide range of indications such as rheumatoid arthritis, multiple sclerosis, diabetes, and anaphylaxis.
Access Free Sample Papers on Autoinjectors Market spread across 133 Pages, Profiling 13 Companies and Supported with 66 Tables and 36 Figures is now available at https://www.reportsnreports.com/contacts/requestsample.aspx?name=1592468 .
Global auto injectors market expected to reach USD 85.31 billion by 2023 from an estimated USD 28.91 billion in 2018, at a CAGR of 24.2% during forecast period. Growing prevalence of targeted therapies, rising incidence of anaphylaxis, increasing number of regulatory approvals, and technological advancements in auto injector devices are expected to drive growth of auto injectors market.
Diabetes mellitus, commonly known as diabetes, is a disease which arises from the insufficient production of insulin or the inability of the body to utilize insulin. The lack of insulin production or the inability of the body to utilize secreted insulin leads to the rise in blood glucose levels. Thus, in order to maintain healthy blood glucose levels, diabetes patients need a daily intake of insulin or Glucagon-like peptide-1 (GLP-1). GLP-1 therapy is delivered through pen devices as well as autoinjector devices. Currently, there are only two autoinjectors available for GLP-1 analogue, namely, Trulicity (dulaglutide) by Eli Lilly and Bydureon BCise (exenatide) by AstraZeneca.
North America is expected to witness the highest growth from 2018 to 2023. This can be attributed to the rising prevalence of anaphylaxis, autoimmune diseases, and chronic diseases in the US and Canada; favorable reimbursement scenario; and increasing number of awareness programs in the region.
Click Here for More Information on Autoinjectors Market Now at https://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=1592468 .
The key players in the global autoinjectorsmarket are Abbvie (US), Amgen (US), Teva (Israel), Biogen (US), Eli Lilly (US), and Mylan (US), Merck (US), Ypsomed (Switzerland), AstraZeneca (UK), J&J (US), Becton Dickinson and Company (US), Owen Mumford (UK), Novartis (Switzerland), Bayer (Germany), and Haselmeier (Switzerland).
Competitive Landscape
1 Overview
2 Market Share Analysis
3 Market Ranking of OEM Companies
4 Market Share Analysis, By Therapeutic Area
5 Rheumatoid Arthritis
6 Multiple Sclerosis
7 Diabetes
8 Anaphylaxis
9 Competitive Scenario
10 Product Launches and Approvals
11 Expansions
12 Agreements, Collaborations, and Partnerships
North America is expected to witness the highest growth from 2018 to 2023. This can be attributed to the rising prevalence of anaphylaxis, autoimmune diseases, and chronic diseases in the US and Canada; favorable reimbursement scenario; and increasing number of awareness programs in the region.
Get 15% Discount on “Autoinjectors Market by Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Anaphylaxis, Cardiovascular diseases, Psoriasis, Migraine), Type (Disposable, and Reusable), End Users (Homecare, and Hospitals) - Global Forecast to 2023” report @ https://www.reportsnreports.com/contacts/discount.aspx?name=1592468 .
Objectives of Autoinjectors Market Study
• To define, measure, and describe the global autoinjectors market by therapy, type, end user, and region
• To provide detailed information about the major factors influencing market growth (drivers, restraints, challenges, and opportunities)
• To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
• To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
• To forecast the size of market segments in North America, Europe, Asia Pacific, and RoW
• To strategically analyze the market structure and profile key players in the global autoinjectors market and comprehensively analyze their core competencies
• To track and analyze company developments such as partnerships, agreements, and collaborations; expansions; product approvals; and product launches in the autoinjectors market
Access Free Sample Papers on Autoinjectors Market spread across 133 Pages, Profiling 13 Companies and Supported with 66 Tables and 36 Figures is now available at https://www.reportsnreports.com/contacts/requestsample.aspx?name=1592468 .
Global auto injectors market expected to reach USD 85.31 billion by 2023 from an estimated USD 28.91 billion in 2018, at a CAGR of 24.2% during forecast period. Growing prevalence of targeted therapies, rising incidence of anaphylaxis, increasing number of regulatory approvals, and technological advancements in auto injector devices are expected to drive growth of auto injectors market.
Diabetes mellitus, commonly known as diabetes, is a disease which arises from the insufficient production of insulin or the inability of the body to utilize insulin. The lack of insulin production or the inability of the body to utilize secreted insulin leads to the rise in blood glucose levels. Thus, in order to maintain healthy blood glucose levels, diabetes patients need a daily intake of insulin or Glucagon-like peptide-1 (GLP-1). GLP-1 therapy is delivered through pen devices as well as autoinjector devices. Currently, there are only two autoinjectors available for GLP-1 analogue, namely, Trulicity (dulaglutide) by Eli Lilly and Bydureon BCise (exenatide) by AstraZeneca.
North America is expected to witness the highest growth from 2018 to 2023. This can be attributed to the rising prevalence of anaphylaxis, autoimmune diseases, and chronic diseases in the US and Canada; favorable reimbursement scenario; and increasing number of awareness programs in the region.
Click Here for More Information on Autoinjectors Market Now at https://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=1592468 .
The key players in the global autoinjectorsmarket are Abbvie (US), Amgen (US), Teva (Israel), Biogen (US), Eli Lilly (US), and Mylan (US), Merck (US), Ypsomed (Switzerland), AstraZeneca (UK), J&J (US), Becton Dickinson and Company (US), Owen Mumford (UK), Novartis (Switzerland), Bayer (Germany), and Haselmeier (Switzerland).
Competitive Landscape
1 Overview
2 Market Share Analysis
3 Market Ranking of OEM Companies
4 Market Share Analysis, By Therapeutic Area
5 Rheumatoid Arthritis
6 Multiple Sclerosis
7 Diabetes
8 Anaphylaxis
9 Competitive Scenario
10 Product Launches and Approvals
11 Expansions
12 Agreements, Collaborations, and Partnerships
North America is expected to witness the highest growth from 2018 to 2023. This can be attributed to the rising prevalence of anaphylaxis, autoimmune diseases, and chronic diseases in the US and Canada; favorable reimbursement scenario; and increasing number of awareness programs in the region.
Get 15% Discount on “Autoinjectors Market by Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Anaphylaxis, Cardiovascular diseases, Psoriasis, Migraine), Type (Disposable, and Reusable), End Users (Homecare, and Hospitals) - Global Forecast to 2023” report @ https://www.reportsnreports.com/contacts/discount.aspx?name=1592468 .
Objectives of Autoinjectors Market Study
• To define, measure, and describe the global autoinjectors market by therapy, type, end user, and region
• To provide detailed information about the major factors influencing market growth (drivers, restraints, challenges, and opportunities)
• To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
• To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
• To forecast the size of market segments in North America, Europe, Asia Pacific, and RoW
• To strategically analyze the market structure and profile key players in the global autoinjectors market and comprehensively analyze their core competencies
• To track and analyze company developments such as partnerships, agreements, and collaborations; expansions; product approvals; and product launches in the autoinjectors market
Contact Information:
ReportsnReports
Vishal
Tel: + 18883915441
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsnReports
Vishal
Tel: + 18883915441
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results